Progenics Pharma (PGNX) – FDA News
-
Progenics Pharma (PGNX) Phase 3 CONDOR Trial of PyL in Prostate Cancer Achieved Primary Endpoint
-
Progenics Pharma (PGNX) Announces CMS Grants New Technology Add-On Payment for Inpatient Use of AZEDRA
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PGNX Stock Lookup